Ann: Trading Halt, page-32

Yes agreed, format, almost identical.

Data? Nah quite different.

I think most of you get it but in case...

This is notably different as we get more idea of separation...how does the active differ from the placebo at a later stage in time...what is happening with processes and the pathophysiology within the joint and even extrinsically to the joint at a later stage in time.

We also get the objective MRI depictions as we have had PAR state in the last presso.





Yeah that's good stuff but look at this...






To me? That's comprehensive. The above slide does things for me in my head...my neurons are getting fired up...we have been researching this for some time now...its culminating nicely (potentially!) now...as we hit that vortex...

Who does such a comprehensive study when we didn't have to, all the FDA really wanted is Pain and Function and with a safe profile...what are we giving them, what does our drug do?



4 days...